|
MGAT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43309999999886E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.53409999995124E-06 |
| Normal-vs-Stage2 |
8.145900E-02 |
| Normal-vs-Stage3 |
3.488000E-02 |
| Normal-vs-Stage4 |
1.705720E-02 |
| Stage1-vs-Stage2 |
1.971820E-01 |
| Stage1-vs-Stage3 |
7.006200E-01 |
| Stage1-vs-Stage4 |
8.037400E-01 |
| Stage2-vs-Stage3 |
6.110400E-01 |
| Stage2-vs-Stage4 |
5.091000E-01 |
| Stage3-vs-Stage4 |
9.059400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70430000000699E-05 |
| Normal-vs-AfricanAmerican |
1.325890E-02 |
| Normal-vs-Asian |
2.889200E-01 |
| Caucasian-vs-AfricanAmerican |
6.196800E-01 |
| Caucasian-vs-Asian |
4.513600E-01 |
| AfricanAmerican-vs-Asian |
7.621000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.199830E-03 |
| Normal-vs-Female |
1.22499999999359E-06 |
| Male-vs-Female |
1.231980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.411900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.01249999999665E-05 |
| Normal-vs-Age(61-80Yrs) |
1.044450E-03 |
| Normal-vs-Age(81-100Yrs) |
2.349400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.644000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.646800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.401800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.822600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.518400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.465800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.036380E-03 |
| Normal-vs-Grade 2 |
5.84510000000149E-05 |
| Normal-vs-Grade 3 |
3.898200E-03 |
| Normal-vs-Grade 4 |
1.702410E-02 |
| Grade 1-vs-Grade 2 |
4.671800E-01 |
| Grade 1-vs-Grade 3 |
1.803040E-01 |
| Grade 1-vs-Grade 4 |
3.865800E-01 |
| Grade 2-vs-Grade 3 |
8.502200E-02 |
| Grade 2-vs-Grade 4 |
7.428200E-01 |
| Grade 3-vs-Grade 4 |
4.352800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.80719999998136E-06 |
| Normal-vs-ccB subtype |
7.363300E-03 |
| ccA subtype-vs-ccB subtype |
5.769000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.371800E-04 |
| Normal-vs-N1 |
2.716400E-01 |
| N0-vs-N1 |
5.597400E-01 |
|
|
